Takeda Pharmaceutical Company Limited (TYO: 4502)
Japan
· Delayed Price · Currency is JPY 4,105.00
+10.00 (0.24%)
Dec 20, 2024, 3:45 PM JST
Takeda Pharmaceutical Company Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,507,166 | 6,564,378 | 6,762,204 | 5,423,454 | 6,229,971 | 5,153,364 | Upgrade
|
| Market Cap Growth | -9.87% | -2.93% | 24.68% | -12.95% | 20.89% | -26.69% | Upgrade
|
| Enterprise Value | 11,258,388 | 11,482,982 | 10,868,028 | 9,054,481 | 10,862,765 | 10,199,254 | Upgrade
|
| Last Close Price | 4105.00 | 4087.41 | 4077.27 | 3133.44 | 3397.14 | 2697.00 | Upgrade
|
| PE Ratio | 22.55 | 45.56 | 21.33 | 23.57 | 16.57 | 116.48 | Upgrade
|
| Forward PE | 37.86 | 31.03 | 21.61 | 14.12 | 18.44 | - | Upgrade
|
| PS Ratio | 1.42 | 1.54 | 1.68 | 1.52 | 1.95 | 1.57 | Upgrade
|
| PB Ratio | 0.94 | 0.90 | 1.06 | 0.95 | 1.20 | 1.09 | Upgrade
|
| P/FCF Ratio | 9.60 | 12.14 | 8.08 | 5.42 | 6.92 | 9.50 | Upgrade
|
| P/OCF Ratio | 7.42 | 9.16 | 6.92 | 4.83 | 6.16 | 7.69 | Upgrade
|
| PEG Ratio | 4.03 | 18.99 | 2.83 | - | 0.33 | - | Upgrade
|
| EV/Sales Ratio | 2.48 | 2.69 | 2.70 | 2.54 | 3.40 | 3.10 | Upgrade
|
| EV/EBITDA Ratio | 8.14 | 10.09 | 8.98 | 7.65 | 11.04 | 11.59 | Upgrade
|
| EV/EBIT Ratio | 17.13 | 23.28 | 17.54 | 15.09 | 25.62 | 34.38 | Upgrade
|
| EV/FCF Ratio | 16.61 | 21.23 | 12.99 | 9.06 | 12.07 | 18.79 | Upgrade
|
| Debt / Equity Ratio | 0.81 | 0.75 | 0.77 | 0.85 | 0.98 | 1.16 | Upgrade
|
| Debt / EBITDA Ratio | 4.07 | 4.60 | 3.86 | 4.07 | 5.16 | 6.21 | Upgrade
|
| Debt / FCF Ratio | 8.28 | 10.10 | 5.81 | 4.81 | 5.64 | 10.07 | Upgrade
|
| Asset Turnover | 0.31 | 0.29 | 0.30 | 0.27 | 0.25 | 0.25 | Upgrade
|
| Inventory Turnover | 1.31 | 1.30 | 1.36 | 1.40 | 1.34 | 1.33 | Upgrade
|
| Quick Ratio | 0.66 | 0.50 | 0.49 | 0.73 | 1.00 | 0.65 | Upgrade
|
| Current Ratio | 1.28 | 1.11 | 0.97 | 1.21 | 1.53 | 1.13 | Upgrade
|
| Return on Equity (ROE) | 4.15% | 2.12% | 5.27% | 4.24% | 7.60% | 0.89% | Upgrade
|
| Return on Assets (ROA) | 2.77% | 2.12% | 2.85% | 2.87% | 2.06% | 1.39% | Upgrade
|
| Return on Capital (ROIC) | 3.29% | 2.57% | 3.57% | 3.62% | 2.59% | 1.74% | Upgrade
|
| Earnings Yield | 4.43% | 2.19% | 4.69% | 4.24% | 6.04% | 0.86% | Upgrade
|
| FCF Yield | 10.42% | 8.24% | 12.37% | 18.44% | 14.44% | 10.53% | Upgrade
|
| Dividend Yield | 4.77% | 4.60% | 4.41% | 5.74% | 5.30% | 6.67% | Upgrade
|
| Payout Ratio | 101.62% | 199.34% | 88.14% | 123.30% | 75.36% | 638.73% | Upgrade
|
| Buyback Yield / Dilution | -1.07% | -0.67% | 0.46% | -0.23% | -0.47% | -61.98% | Upgrade
|
| Total Shareholder Return | 3.70% | 3.93% | 4.88% | 5.51% | 4.83% | -55.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.